Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
NCT01527435
·
clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Exudative Age-Related Macular Degeneration
Sponsor
The Retina Center of St. Louis County, PC
Collaborators
[object Object]